July 6, 2026: FDA Issues Correction Information for North American Rescue First Aid Kits Containing TRUE METRIX Devices

Source Information

Issuing authority: U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH)
Original page date: June 26, 2026
Publication date: July 6, 2026
Source: FDA — First Aid Kit Correction: North American Rescue Updates Use Instructions for First Aid Kits Containing TRUE METRIX Devices

Full Translation of the FDA Notice

FDA issues correction information for North American Rescue first aid kits containing TRUE METRIX devices

The FDA has published correction information for first aid kits from North American Rescue that contain devices affected by the Trividia TRUE METRIX blood glucose monitoring system recall.

According to the FDA page, North American Rescue is updating the instructions for use for certain first aid kits because those kits contain devices affected by the Trividia TRUE METRIX blood glucose monitoring system recall. The notice illustrates that post-market risk for medical devices can originate not only from the primary device itself, but also from combination kits, sets, or companion devices within the supply chain.

Compliance management for first aid kits, combination packs and medical kits therefore needs to address the sourcing of internal components, lot traceability, labeling and instructions, replacement strategy and user notification. Where a component within a kit is subject to a recall, the kit holder should also assess whether its own products and customers are affected.

For exporting manufacturers, combination-sold products should be supported by a component list and a supplier change-tracking mechanism, so that the regulatory status of the devices inside the pack is not overlooked in favour of managing only the final packaging.

AIMEILI Regulatory Interpretation

The value of FDA recall and correction notices of this kind is not limited to alerting companies to a particular brand or model. Such notices reflect how mature markets actually examine post-market system capability. Regulators are not assessing whether a company has written complaint handling, recall and CAPA procedures; they are assessing whether, once a problem arises, the company can rapidly identify affected products, define the risk classification, notify customers, trace lots, control inventory, update instructions for use, and drive corrective actions through design, production, suppliers and user training.

For Chinese medical device manufacturers, where a product is an active device, an implant, an infusion system, a life-support device, a home monitoring device, or a software-controlled device, publicly available FDA recall cases should be incorporated into the post-market risk library. Before registration, companies should not only prepare performance testing and technical files, but also establish in advance complaint classification, adverse event assessment, field safety corrective action, recall simulation, distributor notification and overseas customer response mechanisms. Otherwise, even if the initial registration succeeds, insufficient post-market response capability after market entry may damage brand credibility and affect subsequent registration maintenance.

AIMEILI recommends that companies establish an internal similar-product recall review table, recording item by item the source of the issue, the potential harm, the regulatory classification, the actions taken by the company concerned, the actions required of users, and the corresponding risk to the company's own product. This exercise directly feeds back into risk management, the post-market surveillance (PMS) plan, labeling and instructions for use, human factors validation and the CAPA system. It is a key step for going-global companies moving from a certificate-acquisition mindset to a continuous-compliance mindset.

Business Impact

This update may affect a company's assessment of its registration pathway, technical file preparation, labeling and instructions for use, quality management system records, or post-market maintenance arrangements. Companies should carry out an internal assessment in light of target markets, product risk class, existing certificates and sales plans, rather than treating regulatory news as general reading.

Compliance Actions Companies Should Consider

• Confirm whether this update affects existing registration pathways, certificate maintenance or post-market obligations.
• Verify the technical file, labeling and instructions for use, quality management system and local responsible party arrangements for each target country.
• Establish change impact assessments and a regulatory update tracking record for products already on the market.
• Where necessary, archive the official notice, the translated analysis and internal action items to support later audits and project reviews.

Scope and Applicability

This article is prepared for preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of the regulatory authority in the target country, testing conclusions or legal advice. Official regulatory authorities, international organizations, standards bodies and publicly available regulatory materials are used as primary references, with industry media and project experience serving only as supporting judgement.